Showing results (581-590 of 619) with videos related to

Sort By:
Pageof 62
Population Health Metrics|May 29, 2007
Descriptive epidemiology of selected birth defects, areas of Lombardy, Italy, 1999Giovanna Tagliabue, Roberto Tessandori, Fausta Caramaschi, et al.
Epidemiology (Cambridge, Mass.)|January 4, 2001
A multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupationA S Costantini, L Miligi, D Kriebel, et al.
Veterinary Anaesthesia and Analgesia|November 4, 2025
Reproducibility and diagnostic accuracy of the Unesp-Botucatu Feline Pain Scale and the visual analogue scale among laypeople, cat owners, students and experienced veterinariansMirella M Neves, Mayara T de Lima, Pedro H E Trindade, et al.
Journal of Medicinal Chemistry|July 6, 2021
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)Markus Klein, Michael Busch, Manja Friese-Hamim, et al.
Peerj|March 29, 2022
Multilingual validation of the short form of the Unesp-Botucatu Feline Pain Scale (UFEPS-SF)Stelio P L Luna, Pedro H E Trindade, Beatriz P Monteiro, et al.
European Journal of Medicinal Chemistry|January 19, 2023
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)Giovanni Graziano, Pietro Delre, Francesca Carofiglio, et al.
BMC Public Health|July 13, 2013
Towards the eradication of HPV infection through universal specific vaccinationPiergiorgio Crosignani, Antonella De Stefani, Gaetano Maria Fara, et al.
Journal of Medicinal Chemistry|December 21, 2022
Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide HydrolaseFrancesca Intranuovo, Leonardo Brunetti, Pietro DelRe, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium ChannelsAlessandro Farinato, Maria Maddalena Cavalluzzi, Concetta Altamura, et al.
Biotechnology Reports (Amsterdam, Netherlands)|January 29, 2026
Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint DiseaseValentina Varela, Monique Costa, Cecilia Maciel, et al.
Pageof 62